Biocon Shares slide 4% as Malaysia Unit Red Flagged by USFDA

Lupin share jumps 3% on launching anesthesia injection in US

Biocon share is engaged in the business of manufacture of biotechnology products and research services. Shares of Biocon tumbled 4% on 18 October after the company’s Malaysia unit was red-flagged by the USFDA (US Food and Drug Administration). The company announced that its Malaysian insulin manufacturing facility was classified as “Official Action Needed” (OIA) by … Read more